Stefan Feiten

Koblenz, RP, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Real-World Experiences in the Treatment of Immune Thrombocytopenia over a 2-Year Period.

Real-World Experiences in the Treatment of Immune Thrombocytopenia over a 2-Year Period.

Journal: Oncology research and treatment
Published: March 19, 2026

Vulnerability to Infections and Secondary Immunodeficiencies in Patients with Non-Hodgkin's Lymphomas Starting Anti-CD20 Antibody-Containing Therapies.

Vulnerability to Infections and Secondary Immunodeficiencies in Patients with Non-Hodgkin's Lymphomas Starting Anti-CD20 Antibody-Containing Therapies.

Journal: Oncology research and treatment
Published: August 18, 2025

Metastatic Breast Cancer: Prolonging Life in Routine Oncology Care.

Metastatic Breast Cancer: Prolonging Life in Routine Oncology Care.

Journal: Cancers
Published: February 19, 2024

Patients with indolent lymphomas are at high risk of infections: experience from a German outpatient clinic.

Patients with indolent lymphomas are at high risk of infections: experience from a German outpatient clinic.

Journal: BMC immunology
Published: February 21, 2022

Curricular course for medical students at a hematology and oncology specialty practice, 2010-2022.

Curricular course for medical students at a hematology and oncology specialty practice, 2010-2022.

Journal: GMS journal for medical education
Published: September 06, 2021

Shared decision-making in routine breast cancer care in Germany-A cross-sectional study.

Shared decision-making in routine breast cancer care in Germany-A cross-sectional study.

Journal: Psycho-oncology
Published: August 27, 2021

DNVF Memorandum Health Services Research in Oncology

DNVF Memorandum Health Services Research in Oncology

Journal: Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))
Published: August 29, 2020

Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacement.

Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacement.

Journal: BMC immunology
Published: March 17, 2020

Survival improvement of patients with chronic lymphocytic leukemia (CLL) in routine care 1995-2017.

Survival improvement of patients with chronic lymphocytic leukemia (CLL) in routine care 1995-2017.

Journal: Leukemia & lymphoma
Published: November 05, 2019

Response to the letter to the Editor concerning our article "High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany".

Response to the letter to the Editor concerning our article "High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany".

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: September 23, 2019

High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany.

High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: September 20, 2018

Successful Evidence-Based Treatment of Patients with Advanced Pancreatic Cancer in Community-Based Oncology Group Practices.

Successful Evidence-Based Treatment of Patients with Advanced Pancreatic Cancer in Community-Based Oncology Group Practices.

Journal: Oncology research and treatment
Published: May 09, 2017
Showing 1-12 of 20

Last Updated: 09/26/2026